Waban Software Announces Availability of Next-Generation LIMS at 40th DIA Annual Meeting
Waban Software, a leading provider of software solutions to pharmaceutical and biotechnology companies for data capture, integration, analysis and delivery, today announced the availability of Waban LIMS 1.7 at the 40th DIA Annual Meeting in Washington DC. The next-generation system provides features for managing more efficient lab operations during drug discovery processes, including a modular architecture that enables rapid 21 CFR compliance software updates and aids researchers and developers in managing vast amounts of laboratory data and decision analytics through seamless integration with emerging third-party technologies and applications for genomics, proteomics and pharmacogenomics.
Waban LIMS is a 21 CFR Part 11 compliant, web-based information system designed to manage laboratory workflow and processes. Some of the key features of Waban LIMS 1.7 are:
- A modular architecture that enables the addition of new functionality without the need to re-validate the entire system as changes are required.
- Increased integration with third-party technologies that provide advanced support for clinical diagnostics and the study of genomics, proteomics, pharmacogenomics.
- Patent-pending technology for data-driven LIMS configuration, enabling users to quickly map any number of laboratory processes as SOPs without reprogramming the system.
- Improved capabilities to track samples, capture laboratory processes, manage workflow, and quickly generate standard and customized reports.
- Web-based, reporting components.
- Support for a wide variety of instrument interfaces.
- Optional Anoymization Module for informed consent management, de-identification, re-identification and anonymization of patient information for applications in clinical research and diagnostics.
- Seamless Integration with Waban’ Explore –Waban Software’s Data Warehousing Products.
Waban’s software solutions are uniquely designed to scale and adapt to the changing needs of any lab operation. For pharmaceutical and biotechnology companies that require more advanced capabilities for data management, integration, and analysis throughout drug discovery and development processes, Waban LIMS 1.7 can be integrated with Waban Explorer, Waban’s comprehensive data warehouse solution. Using the two systems together, organizations can rapidly explore and browse vast amounts of data for high throughput research, more rapid decision making during drug discovery and target validation phases, and faster preparation of materials for FDA regulatory submission.
“Waban aims to provide the latest innovations in life sciences information management based on real-life customer requirements,” said Pankaj Tyagi, Vice President of Product Development for Waban Software. “It’s our mission to deliver products that capture the best practices of the domain, lower risk and help get drugs to market faster, and are flexible enough to support changing requirements in data analysis brought about by the fast-moving developments in personalized medicine and clinical diagnostics.”
About Waban Software
Waban Software provides life sciences information management solutions that enable pharmaceutical and biotechnology companies to easily capture, integrate, access, manage and analyze life sciences and clinical trial data on a single platform. Waban’s solutions help companies such as Johnson & Johnson, Bristol-Myers Squibb, Genaissance Pharmaceuticals, Human Genome Sciences and PPD to significantly streamline the management of data from drug discovery and development processes, enabling more rapid analysis and submission to regulatory authorities. The privately held company is based in Cambridge, Massachusetts. For more information, visit www.wabansoftware.com .
